+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Orexin Receptor"

Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
Excessive Daytime Sleepiness - Pipeline Insight, 2024 - Product Thumbnail Image

Excessive Daytime Sleepiness - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
Sleep Disorder Treatment Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Sleep Disorder Treatment Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
From
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
Market Spotlight: Insomnia (2020) - Product Thumbnail Image

Market Spotlight: Insomnia (2020)

  • Report
  • March 2020
  • 44 Pages
  • Global
From
Orexin Receptor Type 1 - Drugs In Development, 2021 - Product Thumbnail Image

Orexin Receptor Type 1 - Drugs In Development, 2021

  • Report
  • July 2021
  • 85 Pages
  • Global
From
From
From
Loading Indicator

The Orexin Receptor market is a subset of the Central Nervous System Drugs market. It is composed of drugs that target the Orexin Receptor, a protein found in the brain that is involved in the regulation of sleep and wakefulness. Orexin Receptor agonists are used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. Orexin Receptor antagonists are used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep. The Orexin Receptor market is a rapidly growing segment of the Central Nervous System Drugs market. It is expected to experience strong growth in the coming years due to the increasing prevalence of sleep disorders and the development of new drugs targeting the Orexin Receptor. Some companies in the Orexin Receptor market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and Takeda. Show Less Read more